Choose Your News
Japanese firms aren't known for disciplined dealmaking. [Read More]
Takeda Pharmaceutical Co. sweetened its offer for drugmaker Shire PLC to more than $60 billion after three prior bids were rejected, wooing investors in th... [Read More]
The Japanese pharmaceuticals company stalking the London-listed Shire has sweetened its takeover offer.Takeda said that it had made an improved proposal of £47 a share... [Read More]
Japanese drug maker Takeda has upped its offer to buy Irish rival Shire for a fourth time, pushing its bid to £42. [Read More]
The brouhaha surrounding Shire continued Friday after Takeda made a fourth bid to buy the drugmaker, sweetening the pot from an earlier bid that valued... [Read More]
Japanese drugs firm Takeda on Friday upped its takeover bid to $60.7 billion (49 billion euros) for Irish-based peer Shire, which has already rejected its... [Read More]
Japan's Takeda Pharmaceutical nudged up its offer for Shire to 44.3 billion pounds ($62 billion) on Friday to try to persuade the rare-disease drugs specialist... [Read More]
Drug-making giant Allergan says it has no plans to make a massive bid for biotech firm Shire, the latest twist in a saga that has... [Read More]
Japan's Takeda said it had made a sweetened proposal to buy Shire after its three previous bids for the rival drugmaker that has drawn broader... [Read More]
Shire (SHPG) declines Takeda Pharmaceutical's third acquisition offer in a cash-stock deal. [Read More]
CNBC's David Faber reports that Japanese drug company Takeda is increasing its proposal for Shire. [Read More]
Japan's Takeda Pharmaceutical Co Ltd increased its offer for Shire to 47 pounds a share on Friday after its three previous bids... [Read More]
Takeda is considering a new bid for Adderall drugmaker Shire, raising the share price to 47 British pounds (about $66) per share up from 46.50... [Read More]
Britain's FTSE 100 index is seen opening 21 points higher at 7,350 on Friday, according to financial bookmakers. ... [Read More]
Shares in Japanese drug maker Takeda dropped Friday after a potential rival in its bid to take over Ireland's Shire Pharmaceuticals said it was no... [Read More]
Japan's Takeda Pharmaceutical Co Ltd shares fell on Friday after rare disease drug maker Shire Plc rejected its $63 billion cash-and-stock acquisition offer. [Read More]
Shire is reportedly in the middle of a bidding war after it rejected three proposals from Takeda and then received new interest from Allergan, according... [Read More]
Shire rejected Takeda's $60 billion takeover bid on Thursday, and now Allergan's reportedly entering the bidding war. The $60 billion bid was a 50%... [Read More]
Reuters Shire rejected Takeda's $60 billion takeover bid on Thursday morning. Allergan then confirmed it was "in the early stages of considering... [Read More]